Skip to main content

Animations

MJFF Publications

7361 - 7370 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2019
  • 2020
  • 2025
  • 2020
  • 2015
  • 2020
  • 2016
  • 2025
  • 2024
  • Summary Details
    RESTRICTED
    Title: Two-phase hybrid explainable machine learning model in the early diagnosis of motor and non-motor symptoms of Parkinson’s disease
    Journal Name: Neurocomputing
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neucom.2025.130004
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci.insight.126769
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Cortical disinhibition in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa274
    Citation Count: 68
  • Summary Details
    OPEN
    Title: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43587-025-00926-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1093/nar/gkaa309
    Citation Count: 168
  • Summary Details
    OPEN
    Title: Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
    Journal Name: Neuropathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/neup.12189
    Citation Count: 427
  • Summary Details
    OPEN
    Title: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11481-020-09909-8
    Citation Count: 19
  • Summary Details
    OPEN
    Title: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.19809
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2025.101999
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Somatic instability of the FGF14 -SCA27B GAA•TTC repeat reveals a marked expansion bias in the cerebellum
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae312
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.